Pharmacy Times

MARCH 29, 2025

Rivaroxaban offers more predictable dosing, eliminates frequent blood tests, and is less likely to interact with foods.

Food 33

Food 33

Pharmacy Times

MARCH 29, 2025

Christian Ruff, MD, highlights abelacimabs potential to significantly reduce bleeding in patients with high-risk atrial fibrillation.

Safety 29

Safety Patients 29

Pharmacy Times

MARCH 29, 2025

The availability of this option could make physicians more comfortable when prescribing ticagrelor, which could help solve the challenge of undertreatment with antiplatelet therapy.

Physicians 29

Physicians 29

Pharmacy Times

MARCH 29, 2025

The results should lead to a guideline update recommending extended treatment with a reduced-dose anticoagulant in this patient population.

Patients 29

Patients Leads 29

Advertiser: ZoomInfo

AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.

Sales

Pharmacy Times

MARCH 29, 2025

PD-L1 immune checkpoint inhibitors are now standard for early-stage non-metastatic non-small cell lung cancer (NSCLC), with neoadjuvant, adjuvant, and perioperative strategies improving survival and outcomes.

26

26

Pharmacy Times

MARCH 29, 2025

The STRIDE trial was first of its kind to evaluate the use of a GLP-1 agonist in PAD management.

Management 52

Management 52